• A case of alveolar soft tissue sarcoma detected by ultrasound examination
• Advances in treatment of alveolar soft part sarcoma: an updated review
• Alveolar soft part sarcoma in a child - a case report
• Alveolar Soft Part Sarcoma in the Female Genital Tract: Case Series with Literature Review and SEER Database Analysis
• Alveolar Soft Part Sarcoma of the Nasolabial Fold: A Case Report and Literature Review
• Alveolar Soft Part Sarcoma of the Tongue: A Rare Tumor at an Unusual Location
• Alveolar soft part sarcoma of the uterine corpus: A 13-year follow-up case report and review of the literature
• Alveolar Soft Part Sarcoma-The Angiogenic Mechanism Regulated by a Fusion Gene Product
• Alveolar soft part sarcoma: a clinicopathological and immunohistochemical analysis of 26 cases emphasizing risk factors and prognosis
• Alveolar soft part sarcoma: Prolonged response to immune checkpoint inhibitors
• Alveolar soft part sarcomas in young patients: The French national NETSARC+ network experience
• Alveolar Soft Tissue Sarcoma in the Right Thigh: A Case Study at King Abdulaziz Medical City, Jeddah, Saudi Arabia
• Alveolar Soft Tissue Sarcoma: Correlation of MRI Features With Histological Grading and Patient Prognosis
• An unusual case of primary splenic soft part alveolar sarcoma: case report and review of the literature with emphasis on the spectrum of TFE3-associated neoplasms
• Analysis of ultrasound images features and diagnostic model establishment of alveolar soft part sarcoma and intramuscular capillary-type hemangiomas
• ASPSCR-1 and Sirt-5 alleviate Clonorchis liver fluke rCs NOSIP-induced oxidative stress, proliferation, and migration in cholangiocarcinoma cells
• ASPSCR-1 and Sirt-5 alleviate Clonorchis liver fluke rCsNOSIP-induced oxidative stress, proliferation, and migration in cholangiocarcinoma cells
• ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97
• ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97
• ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs
• Atezolizumab as the First Systemic Therapy Approved for Alveolar Soft Part Sarcoma
• Atezolizumab for Advanced Alveolar Soft Part Sarcoma
• Biological and therapeutic insights from animal modeling of fusion-driven pediatric soft tissue sarcomas
• Can DNA Methylation Profiling Classify Histologic Subtypes and Grades in Soft Tissue Sarcoma?
• Cheek alveolar soft part sarcoma recurrence at the primary site during follow-up: a case report and review of the literature
• Childhood Soft Tissue Sarcoma Treatment (PDQ): Health Professional Version
• Childhood Soft Tissue Sarcoma Treatment (PDQ®): Health Professional Version
• Clinico-Pathological Spectrum of Alveolar Soft Part Sarcoma: Case Series from a Tertiary Care Cancer Referral Centre in India with a Focus on Unusual Clinical and Histological Features
• Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis
• Complete Response to Pembrolizumab in Stage IV Alveolar Soft Part Sarcoma After Failure of Four Lines of Treatment: A Case Report and Literature Review
• Current Landscape of Immunotherapy for Advanced Sarcoma
• Current therapeutic standards in advanced soft tissue sarcomas
• Detection of various fusion genes by one-step RT-PCR and the association with clinicopathological features in 242 cases of soft tissue tumor
• Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial/NCCH1510)
• Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry
• Epigenetic determinants of fusion-driven sarcomas: paradigms and challenges
• Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma
• Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS)
• Exploratory study of an anti-PD-L1/TGF-β antibody, TQB2858, in patients with refractory or recurrent osteosarcoma and alveolar soft part sarcoma: a report from Chinese sarcoma study group (TQB2858-Ib-02)
• Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor
• How to develop new systemic treatments in ultra-rare cancers with high unmet needs? The case of alveolar soft-part sarcoma
• Imaging Features of Alveolar Soft Part Sarcoma: Single Institution Experience and Literature Review
• Immune checkpoint inhibitors in sarcomas: a systematic review
• Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients
• Mesenchymal neoplasms of the tongue: A clinicopathologic study of 93 cases
• Metastatic alveolar soft part sarcoma of the kidney in a young female
• Mimicking angiogenic microenvironment of alveolar soft-part sarcoma in a microfluidic coculture vasculature chip
• PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma
• Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial
• PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications
• Primary gastric alveolar soft part sarcoma
• Primary intracranial alveolar soft part sarcoma in a 22 years old female: a rare case report with literature review
• Primary Uterine Alveolar Soft Part Sarcoma in a Postmenopausal Woman: Histopathologic and Immunohistochemical Characteristics of a Rare Case
• Prognostic factors of alveolar soft part sarcoma in children and adolescents: A population-based study
• Qualitative and quantitative MRI analysis of alveolar soft part sarcoma: correlation with histological grade and Ki-67 expression
• Rare immune-related adverse effect of pembrolizumab: pulmonary hypertension
• Real-world efficacy, safety data and predictive clinical parameters for treatment outcomes in advanced soft tissue sarcoma treated with combined immunotherapy and antiangiogenic therapy
• Recurrent peripartum alveolar soft-part sarcoma: Case report using CARE methodology
• Rhabdomyosarcoma Associated with Core Myopathy/Malignant Hyperthermia: Combined Effect of Germline Variants in <em>RYR1</em> and <em>ASPSCR1</em> May Play a Role
• Severe immediate hypersensitivity to gadolinium contrast agent after targeted treatment in a patient with alveolar soft part sarcoma: A case report and review of literature
• Soft tissue tumor imaging in adults: whole-body staging in sarcoma, non-malignant entities requiring special algorithms, pitfalls and special imaging aspects. Guidelines 2024 from the European Society of Musculoskeletal Radiology (ESSR)
• Structural basis for recognition and methylation of p97 by METTL21D, a valosin-containing protein lysine methyltransferase
• Sustained deep partial response with axitinib and pembrolizumab in a patient with alveolar soft-part sarcoma: A case report and review of the literature
• The dynamic contrast enhanced-magnetic resonance imaging and diffusion-weighted imaging features of alveolar soft part sarcoma
• Treatment of a case of primary alveolar soft part sarcoma of the lung: Case report and literature review
• UBXN9 inhibits the RNA exosome function to promote T cell control of liver tumorigenesis
• Unraveling the Mysteries of alveolar soft part sarcomas in young patients
• Vascular Expression of Prostate-specific Membrane Antigen (PSMA) in MiTF Family Translocation Renal Cell Carcinoma and Related Neoplasms